AU2002335640A1 - Gleason grade 4/5 prostate cancer genes - Google Patents
Gleason grade 4/5 prostate cancer genesInfo
- Publication number
- AU2002335640A1 AU2002335640A1 AU2002335640A AU2002335640A AU2002335640A1 AU 2002335640 A1 AU2002335640 A1 AU 2002335640A1 AU 2002335640 A AU2002335640 A AU 2002335640A AU 2002335640 A AU2002335640 A AU 2002335640A AU 2002335640 A1 AU2002335640 A1 AU 2002335640A1
- Authority
- AU
- Australia
- Prior art keywords
- prostate cancer
- cancer genes
- gleason grade
- gleason
- grade
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31274501P | 2001-08-17 | 2001-08-17 | |
US60/312,745 | 2001-08-17 | ||
PCT/US2002/026081 WO2003016484A2 (en) | 2001-08-17 | 2002-08-16 | Gleason grade 4/5 prostate cancer genes |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002335640A1 true AU2002335640A1 (en) | 2003-03-03 |
Family
ID=23212822
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002335640A Abandoned AU2002335640A1 (en) | 2001-08-17 | 2002-08-16 | Gleason grade 4/5 prostate cancer genes |
Country Status (3)
Country | Link |
---|---|
US (1) | US20030113762A1 (en) |
AU (1) | AU2002335640A1 (en) |
WO (1) | WO2003016484A2 (en) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080050836A1 (en) * | 1998-05-01 | 2008-02-28 | Isabelle Guyon | Biomarkers for screening, predicting, and monitoring benign prostate hyperplasia |
US20090226915A1 (en) | 2001-01-24 | 2009-09-10 | Health Discovery Corporation | Methods for Screening, Predicting and Monitoring Prostate Cancer |
US6949342B2 (en) * | 2001-12-21 | 2005-09-27 | Whitehead Institute For Biomedical Research | Prostate cancer diagnosis and outcome prediction by expression analysis |
US8008012B2 (en) | 2002-01-24 | 2011-08-30 | Health Discovery Corporation | Biomarkers downregulated in prostate cancer |
US20040029151A1 (en) * | 2002-04-09 | 2004-02-12 | Affymetrix, Inc. | Molecular genetic profiling of gleason grades 3 and 4/5 prostate cancer |
US20080014579A1 (en) * | 2003-02-11 | 2008-01-17 | Affymetrix, Inc. | Gene expression profiling in colon cancers |
US7129049B2 (en) * | 2003-12-22 | 2006-10-31 | Regents Of The University Of Minnesota | Method of detecting equine glycogen storage disease IV |
CA2565450C (en) * | 2004-05-07 | 2018-03-06 | Gyorgy Petrovics | Methods of diagnosing or treating prostate cancer using the erg gene, alone or in combination with other over or under expressed genes in prostate cancer |
US11105808B2 (en) | 2004-11-12 | 2021-08-31 | Health Discovery Corporation | Methods for screening, predicting and monitoring prostate cancer |
WO2006091776A2 (en) * | 2005-02-25 | 2006-08-31 | The Brigham And Women's Hospital, Inc. | Biomarkers for predicting prostate cancer progression |
EP1934367B1 (en) * | 2005-09-14 | 2010-11-03 | National Research Council of Canada | Molecular method for diagnosis of prostate cancer |
CN101490088B (en) | 2006-06-22 | 2015-04-08 | 健泰科生物技术公司 | Methods and compositions for targeting hepsin |
JP5272011B2 (en) * | 2007-10-22 | 2013-08-28 | セントビンセンツ ホスピタル シドニー リミテッド | Prognosis determination method |
JP2009268665A (en) * | 2008-05-07 | 2009-11-19 | Canon Inc | Inhalation device |
WO2010065926A2 (en) * | 2008-12-04 | 2010-06-10 | Health Discovery Corporation | Methods for screening, predicting and monitoring prostate cancer |
JP5819308B2 (en) | 2009-10-22 | 2015-11-24 | ジェネンテック, インコーポレイテッド | Methods and compositions for modulating macrophage stimulating protein hepsin activation |
ES2534646T3 (en) | 2009-10-22 | 2015-04-27 | F. Hoffmann-La Roche Ag | Anti-hepsin antibodies and methods of use thereof |
WO2011161189A1 (en) | 2010-06-24 | 2011-12-29 | F. Hoffmann-La Roche Ag | Anti-hepsin antibodies and methods of use |
US20140377220A1 (en) * | 2011-11-23 | 2014-12-25 | Uti Limited Partnership | Gene expression signatures for staging and prognosis of prostate, breast and leukemia cancers |
WO2015131177A1 (en) * | 2014-02-28 | 2015-09-03 | The Johns Hopkins University | Genes encoding secreted proteins which identify clinically significant prostate cancer |
US11845793B2 (en) | 2015-10-30 | 2023-12-19 | Nbe-Therapeutics Ag | Anti-ROR1 antibodies |
JP7000660B2 (en) | 2016-01-20 | 2022-02-04 | ザ スクリプス リサーチ インスティテュート | ROR1 antibody composition and related methods |
RU2764031C2 (en) | 2017-08-07 | 2022-01-12 | ЭнБиИ - ТЕРАПЬЮТИКС АГ | Conjugates of antibodies and drugs characterized in high in vivo tolerance |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5800992A (en) * | 1989-06-07 | 1998-09-01 | Fodor; Stephen P.A. | Method of detecting nucleic acids |
US6309822B1 (en) * | 1989-06-07 | 2001-10-30 | Affymetrix, Inc. | Method for comparing copy number of nucleic acid sequences |
US6309823B1 (en) * | 1993-10-26 | 2001-10-30 | Affymetrix, Inc. | Arrays of nucleic acid probes for analyzing biotransformation genes and methods of using the same |
US6228575B1 (en) * | 1996-02-08 | 2001-05-08 | Affymetrix, Inc. | Chip-based species identification and phenotypic characterization of microorganisms |
WO1997036179A1 (en) * | 1996-03-28 | 1997-10-02 | Dana-Farber Cancer Institute | Transcriptional regulatory sequences and uses thereof |
US6303301B1 (en) * | 1997-01-13 | 2001-10-16 | Affymetrix, Inc. | Expression monitoring for gene function identification |
EP1005546A2 (en) * | 1997-02-25 | 2000-06-07 | Corixa Corporation | Compounds for immunotherapy of prostate cancer and methods for their use |
US6268165B1 (en) * | 1997-03-19 | 2001-07-31 | The Board Of Trustees Of The University Of Arkansas | Methods for the early diagnosis of ovarian cancer |
US5981830A (en) * | 1997-05-30 | 1999-11-09 | Schering Aktiengesellschaft | Knockout mice and their progeny with a disrupted hepsin gene |
US6413780B1 (en) * | 1998-10-14 | 2002-07-02 | Abbott Laboratories | Structure and method for performing a determination of an item of interest in a sample |
US6340565B1 (en) * | 1998-11-03 | 2002-01-22 | Affymetrix, Inc. | Determining signal transduction pathways |
US6258536B1 (en) * | 1998-12-01 | 2001-07-10 | Jonathan Oliner | Expression monitoring of downstream genes in the BRCA1 pathway |
US6413228B1 (en) * | 1998-12-28 | 2002-07-02 | Pro Duct Health, Inc. | Devices, methods and systems for collecting material from a breast duct |
AU3316600A (en) * | 1999-02-22 | 2000-09-21 | Torben F. Orntoft | Gene expression in bladder tumors |
US6423543B1 (en) * | 2000-12-20 | 2002-07-23 | Isis Pharmaceuticals, Inc. | Antisense modulation of hepsin expression |
JP2004526434A (en) * | 2001-01-23 | 2004-09-02 | アイアールエム・リミテッド・ライアビリティ・カンパニー | Genes overexpressed in prostate disorders as diagnostic and therapeutic targets |
US20040029151A1 (en) * | 2002-04-09 | 2004-02-12 | Affymetrix, Inc. | Molecular genetic profiling of gleason grades 3 and 4/5 prostate cancer |
-
2002
- 2002-08-16 AU AU2002335640A patent/AU2002335640A1/en not_active Abandoned
- 2002-08-16 WO PCT/US2002/026081 patent/WO2003016484A2/en not_active Application Discontinuation
- 2002-08-16 US US10/222,206 patent/US20030113762A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2003016484A2 (en) | 2003-02-27 |
WO2003016484A3 (en) | 2003-12-11 |
US20030113762A1 (en) | 2003-06-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002335640A1 (en) | Gleason grade 4/5 prostate cancer genes | |
AU2002362454A1 (en) | Regulated breast cancer genes | |
AU2002212527A1 (en) | Thermometry-based breast cancer risk assessment | |
WO2003018621A8 (en) | Genes | |
AU2001253140A1 (en) | Tumor markers in ovarian cancer | |
AU2002361908A1 (en) | Methods for identifying marker genes for cancer | |
AU2001292802A1 (en) | Genetic markers for tumors | |
AUPQ923100A0 (en) | Treatment of prostate cancer | |
AU2002360345A1 (en) | Prostate cancer genes | |
AU4823599A (en) | Prostate cancer-associated genes | |
AU2003224598A1 (en) | Differentially-regulated prostate cancer genes | |
AU2001227903A1 (en) | Everninomicin biosynthetic genes | |
AU2002307154A1 (en) | Prostate cancer expression profiles | |
AU2002334891A1 (en) | Tumor targeted photodiagnostic-phototherapeutic agents | |
AU2002245717A1 (en) | Oligonucleotide conjugates | |
AU2001240103A1 (en) | Reproduction-specific genes | |
EP1208232A4 (en) | Markers for prostate cancer | |
EP1144631A3 (en) | Insulin-synthesis genes | |
AU5124500A (en) | Tumor necrosis factor-gamma | |
AU2003212826A1 (en) | Cancer genes | |
AU2001257325A1 (en) | Cancer treatment | |
AU2002337695A1 (en) | High-protein-phenotype-associated plant genes | |
AU2001250828A1 (en) | Immunogenic ovarian cancer genes | |
AU5416700A (en) | Differentially expressed genes in prostate cancer | |
AU2002351382A1 (en) | Combination cancer therapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |